0001181431-11-036552.txt : 20110614
0001181431-11-036552.hdr.sgml : 20110614
20110614164650
ACCESSION NUMBER: 0001181431-11-036552
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110610
FILED AS OF DATE: 20110614
DATE AS OF CHANGE: 20110614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Viveash Dawn
CENTRAL INDEX KEY: 0001475720
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33415
FILM NUMBER: 11911031
MAIL ADDRESS:
STREET 1: 3344 N. TORREY PINES CT., SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orexigen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001382911
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 651178822
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3344 N. TORREY PINES CT.
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 875-8600
MAIL ADDRESS:
STREET 1: 3344 N. TORREY PINES CT.
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
rrd315185.xml
VIVEASH JUNE GRANT
X0303
4
2011-06-10
0
0001382911
Orexigen Therapeutics, Inc.
OREX
0001475720
Viveash Dawn
C/O OREXIGEN THERAPEUTICS, INC.
3344 N. TORREY PINES COURT, SUITE 200
LA JOLLA
CA
92037
0
1
0
0
SVP/Head of Regulatory Affairs
Stock Option (right to buy)
1.69
2011-06-10
4
A
0
72000
A
2021-06-09
Common Stock
72000
72000
D
1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant following June 10, 2011, so that all of the shares of the stock subject to the option shall be vested on June 10, 2015, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
Not applicable.
/s/ Heather D. Turner, Attorney-in-Fact
2011-06-14